935 related articles for article (PubMed ID: 25928287)
21. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
22. Impact of extending screening mammography to older women: Information to support informed choices.
Jacklyn G; Howard K; Irwig L; Houssami N; Hersch J; Barratt A
Int J Cancer; 2017 Oct; 141(8):1540-1550. PubMed ID: 28662267
[TBL] [Abstract][Full Text] [Related]
23. United States Preventive Services Task Force screening mammography recommendations: science ignored.
Hendrick RE; Helvie MA
AJR Am J Roentgenol; 2011 Feb; 196(2):W112-6. PubMed ID: 21257850
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
25. Screening mammography--early detection or over-diagnosis? Contribution from Australian data.
Bell RJ
Climacteric; 2014 Dec; 17 Suppl 2():66-72. PubMed ID: 25224048
[TBL] [Abstract][Full Text] [Related]
26. Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision Analyses.
Braithwaite D; Walter LC; Izano M; Kerlikowske K
J Gen Intern Med; 2016 May; 31(5):561-72. PubMed ID: 26831305
[TBL] [Abstract][Full Text] [Related]
27. [Mammography screening].
Zwahlen M; Egger M
Ther Umsch; 2013 Apr; 70(4):205-12; discussion 212-3. PubMed ID: 23535547
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer screening: the evolving evidence.
Smith RA; Duffy SW; Tabár L
Oncology (Williston Park); 2012 May; 26(5):471-5, 479-81, 485-6. PubMed ID: 22730603
[TBL] [Abstract][Full Text] [Related]
29. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.
Miglioretti DL; Lange J; van den Broek JJ; Lee CI; van Ravesteyn NT; Ritley D; Kerlikowske K; Fenton JJ; Melnikow J; de Koning HJ; Hubbard RA
Ann Intern Med; 2016 Feb; 164(4):205-14. PubMed ID: 26756460
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.
Sankatsing VD; Heijnsdijk EA; van Luijt PA; van Ravesteyn NT; Fracheboud J; de Koning HJ
Int J Cancer; 2015 Oct; 137(8):1990-9. PubMed ID: 25895135
[TBL] [Abstract][Full Text] [Related]
31. Screening for breast cancer with mammography.
Gøtzsche PC; Jørgensen KJ
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001877. PubMed ID: 23737396
[TBL] [Abstract][Full Text] [Related]
32. Screening for breast cancer with mammography.
Gøtzsche PC; Nielsen M
Cochrane Database Syst Rev; 2011 Jan; (1):CD001877. PubMed ID: 21249649
[TBL] [Abstract][Full Text] [Related]
33. Screening for breast cancer with mammography.
Gøtzsche PC; Nielsen M
Cochrane Database Syst Rev; 2009 Oct; (4):CD001877. PubMed ID: 19821284
[TBL] [Abstract][Full Text] [Related]
34. Digital mammography screening: weighing reduced mortality against increased overdiagnosis.
de Gelder R; Fracheboud J; Heijnsdijk EA; den Heeten G; Verbeek AL; Broeders MJ; Draisma G; de Koning HJ
Prev Med; 2011 Sep; 53(3):134-40. PubMed ID: 21718717
[TBL] [Abstract][Full Text] [Related]
35. Mammographic screening for breast cancer. Overdiagnosis: an insidious adverse effect of screening.
Prescrire Int; 2015 Jul; 24(162):186-9, 191. PubMed ID: 26240891
[TBL] [Abstract][Full Text] [Related]
36. Screening for breast cancer: an update for the U.S. Preventive Services Task Force.
Nelson HD; Tyne K; Naik A; Bougatsos C; Chan BK; Humphrey L;
Ann Intern Med; 2009 Nov; 151(10):727-37, W237-42. PubMed ID: 19920273
[TBL] [Abstract][Full Text] [Related]
37. Discussing the benefits and harms of screening mammography.
Brennan M; Houssami N
Maturitas; 2016 Oct; 92():150-153. PubMed ID: 27621253
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis.
Magnus MC; Ping M; Shen MM; Bourgeois J; Magnus JH
J Womens Health (Larchmt); 2011 Jun; 20(6):845-52. PubMed ID: 21413892
[TBL] [Abstract][Full Text] [Related]
39. Why mammography screening has not lived up to expectations from the randomised trials.
Gøtzsche PC; Jørgensen KJ; Zahl PH; Mæhlen J
Cancer Causes Control; 2012 Jan; 23(1):15-21. PubMed ID: 22072221
[TBL] [Abstract][Full Text] [Related]
40. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
